Rebalancing academic psychiatry: why it needs to happen – and soon by Arthur Kleinman The British Journal of Psychiatry. 2012 201:421-422. Summary: Academic psychiatry is in trouble, becoming the narrowest of biological research approaches of decreasing relevance to clinical practice and global health. What is required is a rebalancing of the psychiatric academy to include […]
If you choose not to support the DSM-5, there’s nothing to it: American Psychiatric Association (APA) launches new pages for DSM-5 – DSM-5 to cost $199 DxRevisionWatch by Suzy Chapman January 29, 2013 Unless you’ve had your head stuck in a bucket this last three years, you’ll be aware that the next edition of the American Psychiatric […]
PharmaTimes head-to-head debate Whitehead vs Goldacre The Royal Institution, Albemarle Street, London 26 February, 2013 5.00pm onwards Does pharma put profits ahead of patients? Is the industry failing to live up to the legal and moral standards expected of it? Or do its criticisers continue to push historical examples of malpractice and fail to recognise […]
Overseas Clinical Trials: Compare and Contrast Association of Clinical Research Organizations Globalization White Paper This report analyzes the current state of global clinical research and the role that biopharmaceutical companies and their clinical research organization (CRO) partners play in ensuring that the dual goals of trial safety and quality are met. With the changing landscape […]
Health Care’s Trick Coin New York Times: OP-ED By BEN GOLDACRE February 1, 2013 … Withholding data not only misleads doctors and patients; it’s an insult to the patients who have participated in clinical trials, believing that they were helping to improve medical knowledge. Medicine routinely overcomes enormous technical challenges, and there is nothing complicated […]
And by the way, speaking of synchronicity, guess who has an op-ed piece in the New York Times today? Ben Goldacre [Health Care’s Trick Coin]. Now for a chain of hat tips: Pharmagossip by Jack Friday January 30, 2013 Knight Science Journal at MIT by Paul Raeburn January 30, 2013 Science News by Rachel Ehrenberg […]
What with the weather fronts and family medical matters, I’ve been out and about this week, so I enjoyed today’s emptiness with a roaring fire against the southern cold snap, and the space to write the last two posts. After I finished [the posts and the ham sandwich], I scanned my usual blogs and this […]
The article in the last post [gone missing…] compared the studies of the antidepressants submitted to the FDA with the ones that actually got published. But they looked at something else too, something beyond gone missing. They looked at the strength of the drug effect in the FDA version compared to the published versions. That […]
Dr. Ben Goldacre is an entertaining speaker [something of value…, another Ben/TED talk…], a journalist [Bad Science: The Guardian], and the author of several books [Bad Science: Quacks, Hacks, and Big Pharma Flacks, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients]. He’s a major force behind AllTrials [upper left], the petition calling for […]